Sectoral Asset Management »

Bicara Therapeutics shares owned by Sectoral Asset Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Sectoral Asset Management from 13F filings

Historical chart of Sectoral Asset Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Sectoral Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.2M 267k 15.79
2025-06-30 $1.9M 201k 9.29

More positions owned by Sectoral Asset Management

Contineum Therapeutics Cl A (CTNM)
Eli Lilly & Co. (LLY)
Structure Therapeutics Sp Adr (GPCR)
Anaptysbio Inc Common (ANAB)
Shoulder Innovations Common Stock
Arcus Biosciences Incorporated (RCUS)
Immatics Nv SHS (IMTX)
UnitedHealth (UNH)
Bicara Therapeutics (BCAX)
Oric Pharmaceuticals (ORIC)
Solid Biosciences Com New (SLDB)
Kura Oncology (KURA)
Ventyx Biosciences (VTYX)
Abbvie (ABBV)
Mbx Biosciences (MBX)

View all positions for Sectoral Asset Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
Blackstone Group
Millennium Management
Geode Capital Management
Fil
Acorn Capital Advisors

View all funds holding Bicara Therapeutics